Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Crinetics Pharmaceuticals (CRNX) COO sells 9,911 shares for RSU taxes
Crinetics Pharmaceuticals’ Chief Operating Officer, Jeff E. Knight, sold 9,911 shares of common stock on March 16, 2026, to cover tax withholding obligations related to vested restricted stock units. The sales were executed at volume-weighted average prices of $37.11 and $37.77 per share under a Rule 10b5-1 trading plan. Following these transactions, Knight directly holds 112,018 shares of Crinetics common stock.